Product image of Kryptoscan Generator Drn 3633 (Krypton (81mkr)) supplied by GNH India

Kryptoscan Generator Drn 3633

Active Ingredient:
Krypton (81mkr)
Origin:
EU

Kryptoscan Generator Drn 3633 (Krypton (81mkr))

Krypton, the active ingredient in Kryptoscan Generator Drn 3633, is a noble gas presented as a gaseous form for inhalation use. It is employed in diagnostic imaging of the respiratory system, particularly for ventilation studies.
GNH India supplies Kryptoscan Generator Drn 3633 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Manufacturer / TM Owner

Curium Netherlands B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Krypton is employed in nuclear medicine for imaging of the respiratory system.
  • Lung ventilation imaging: enables assessment of regional ventilation in patients undergoing nuclear medicine scans.
  • Pulmonary embolism evaluation: assists in detecting ventilation‑perfusion mismatch during V/Q studies.
  • Pre‑operative lung function assessment: provides functional imaging to guide surgical planning.

How It Works

  • Krypton‑81m, a short‑lived radioactive isotope of krypton, is released from the generator and inhaled, where it distributes uniformly in the alveolar air spaces. Its gamma emissions are captured by scintillation cameras, allowing visualization of ventilation patterns without interacting with biological receptors.

Side Effects

Inhalation of krypton gas may be associated with the following adverse reactions.

Common Side Effects

  • Cough: mild irritation of the airway.
  • Throat discomfort: transient sensation of dryness or soreness.
  • Headache: mild to moderate headache reported post‑procedure.

Serious or Rare Side Effects

  • Hypoxia: rare reduction in blood oxygen levels requiring supplemental oxygen.
  • Allergic reaction: anaphylaxis or severe hypersensitivity, though extremely uncommon.
  • Radiation exposure: unintended high dose due to equipment malfunction.

Precautions & Warnings

  • When using Kryptoscan Generator Drn 3633, consider these safety measures.
  • Patient assessment: evaluate respiratory status before inhalation.
  • Equipment calibration: ensure generator and delivery system are properly calibrated.
  • Radiation safety: follow institutional protocols to limit exposure.
  • Contraindications: avoid in patients with severe obstructive lung disease.
  • Monitoring: observe patients for respiratory distress during and after administration.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Krypton gas may interact with certain agents or conditions.

Major Interactions (Avoid)

  • High‑flow oxygen therapy: can dilute inhaled krypton, reducing image quality.
  • Certain radiopharmaceuticals: simultaneous use may cause overlapping radiation signals.

Moderate Interactions (Monitor Closely)

  • Sedatives: may depress respiratory drive, requiring closer monitoring.
  • Bronchodilators: may alter ventilation distribution, affecting scan interpretation.
  • Contrast agents: may interfere with imaging protocols if administered concurrently.

Frequently Asked Questions

Kryptoscan Generator Drn 3633 provides krypton‑81m gas for inhalation during nuclear medicine procedures. It is primarily used to create ventilation images of the lungs, helping clinicians assess airflow distribution, detect ventilation‑perfusion mismatches, and evaluate lung function before surgery or in the work‑up of pulmonary embolism.

The generator releases krypton‑81m, a short‑lived radioactive isotope. When inhaled, the gas spreads evenly throughout the airways and alveoli. Its gamma emissions are captured by a gamma camera, producing high‑resolution images that reflect regional ventilation without interacting with cellular receptors.

The administered activity is determined by the prescribing physician or nuclear medicine specialist based on the specific imaging protocol, patient size, and equipment calibration. The generator delivers a calibrated amount of krypton‑81m, and the exact dose is set at the point of use.

Data on the use of krypton‑81m during pregnancy or lactation are limited. Because it involves ionising radiation, the product should only be used when the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and only under strict medical supervision.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Krypton‑81m offers rapid imaging because of its short half‑life and provides high‑resolution ventilation images without the need for complex ventilation masks. Alternatives such as xenon‑133 have longer half‑lives and may require longer acquisition times, while technetium‑99m agents are used for perfusion rather than ventilation, making krypton‑81m the preferred choice for pure ventilation studies.

The generator should be stored at ambient temperature, protected from moisture and direct sunlight, and kept in its original sealed container until use. Handling must follow radiation safety guidelines, and the device should be inspected for integrity before each use.

The device is connected to a calibrated delivery system that releases krypton‑81m gas for inhalation. The patient breathes the gas through a mouthpiece or mask under controlled conditions while the gamma camera acquires ventilation images. Administration is performed by trained nuclear medicine personnel.

Serious risks include hypoxia if the inhaled gas displaces oxygen, severe allergic reactions (anaphylaxis), and unintended radiation exposure due to equipment malfunction. Immediate medical intervention is required if any of these events occur, and facilities must have emergency protocols in place.

Patients with severe obstructive lung disease, uncontrolled asthma, or known hypersensitivity to krypton‑81m should not undergo the procedure. Additionally, individuals for whom radiation exposure is contraindicated, such as pregnant women without a compelling clinical indication, should avoid its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.